Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 17,000 shares at $180.02 ($3.1M) on 2021-04-01, disclosed to the SEC on 2021-04-02.
Open-market sale of $3.1M TXG by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $180.02 | 300 | $54K | 1.7% |
| 2 | $181.83 | 200 | $36K | 1.2% |
| 3 | $183.19 | 700 | $128K | 4.1% |
| 4 | $184.12 | 3,205 | $590K | 18.8% |
| 5 | $184.12 | 3,205 | $590K | 18.8% |
| 6 | $185.02 | 3,795 |
| $702K |
| 22.4% |
| 7 | $185.02 | 3,795 | $702K | 22.4% |
| 8 | $185.76 | 1,800 | $334K | 10.7% |
| Total | $184.56 avg | 17,000 | $3.1M | 100% |
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |